Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system.
about
Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cost-effectiveness analysis of ...... s in the Slovak health system.
@en
Cost-effectiveness analysis of ...... s in the Slovak health system.
@nl
type
label
Cost-effectiveness analysis of ...... s in the Slovak health system.
@en
Cost-effectiveness analysis of ...... s in the Slovak health system.
@nl
prefLabel
Cost-effectiveness analysis of ...... s in the Slovak health system.
@en
Cost-effectiveness analysis of ...... s in the Slovak health system.
@nl
P2093
P2860
P356
P1476
Cost-effectiveness analysis of ...... s in the Slovak health system.
@en
P2093
Antonio Ramirez de Arellano
Barnaby Hunt
Marek Psota
Maria Bucek Psenkova
Natalia Racekova
Tom Vandebrouck
P2860
P304
P356
10.2147/CEOR.S143127
P407
P577
2017-12-12T00:00:00Z